Real-World Safety and Effectiveness of Omalizumab in Moderate to Severe Allergic Asthma Patients in China: A Post-Authorization Study.

Nan SuLili ZhiFengxia LiuYongsheng WangQingling ZhangXiansheng LiuXueyan WangGuodong HaoXiuqin ZhangQiang HuMonica Ligueros-SaylanAlkaz UddinJing YangTiantian LiangLiju DingRunqin LiChen Wang

Published in: Journal of asthma and allergy (2023)

The findings of the current study demonstrated that the safety profile of omalizumab was consistent with its known profile in allergic asthma, and no new safety signals were reported. Omalizumab treatment was effective in improving the lung function and QoL in patients with allergic asthma.

Keyphrases

lung function
chronic obstructive pulmonary disease
allergic rhinitis
cystic fibrosis
air pollution
randomized controlled trial
end stage renal disease
ejection fraction
systematic review
newly diagnosed
prognostic factors
early onset
drug induced
smoking cessation
replacement therapy